Background. Female same-sex partnerships provide a unique opportunity to study the pathogenesis and transmissibility of bacterial vaginosis (BV) because it can be diagnosed in both members of the partnership. We conducted a nationwide community-enrolled cohort study of women who have sex with women, including women coenrolled with their regular female sexual partner (FSP), to investigate the BV incidence rate and factors associated with incident BV.
Bacterial vaginosis (BV) is one of the most poorly understood conditions in sexual health. Current treatment regimens are associated with high long-term recurrence rates [1] and have had limited impact on BV-associated sequelae [2, 3] . Difficulties encountered in determining its etiology, absence of a clear disease counterpart in males, and failure of male partner treatment trials to affect recurrence [4, 5] have all been significant impediments to determining whether BV is sexually transmitted.
Epidemiological studies in women who have sex with men (WSM) consistently report a strong association between BV and sexual activity. In a university cohort, BV was absent in women with no history of sexual activity and associated with increased lifetime penile-vaginal sex partners [6, 7] . BV has been associated with increased numbers of sexual partners and inconsistent condom use by meta-analysis [8] . Risk of incident BV was reduced in wives of circumcised men in a circumcision trial [9] , and BVassociated bacteria and biofilm have been detected in male genital samples [10] [11] [12] . Collectively, these data indicate that transmission of BV-associated bacterial species between men and women may be occurring.
Although there have been fewer epidemiological studies in women who have sex with women (WSW), BV appears to be common in this population, with prevalence estimates ranging from 25% to 52% [13] [14] [15] [16] [17] . BV has been associated with risk factors implicating sexual transmission between women, including increased number of female sexual partners (FSPs), an FSP with BV symptoms, and receptive oral sex [14, [16] [17] [18] . FSPs in monogamous relationships have been shown to have high concordance of Nugent category [13, 14, 16, 17] , and to share Lactobacillus strain types [19] .
Although these data support the concept of exchange of vaginal bacterial species between women, as in heterosexual couples, sexual transmission of BV has not been established. There has been 1 randomized partner intervention in WSW, which found that minimizing transmission of vaginal fluid through gloves and condom use for sex toys did not reduce recurrence [20] . Female same-sex partnerships provide an important model to understand the pathogenesis and transmissibility of BV as it can be diagnosed in both members of the partnership. We conducted a communitybased cohort study of WSW over a 2-year period to determine incidence of BV and factors associated with incident BV, with the broader aims to inform current evidence regarding sexual transmission of BV and develop more-effective treatment approaches.
METHODS
The Women On Women's (WOW) Health study was a crosssectional study to determine BV prevalence in 458 nonpregnant premenopausal women with an FSP in the prior 18 months [17] . Participants who were BV negative on 3 consecutive weekly vaginal smears were offered enrollment in a 24-month prospective cohort study extending from March 2010 to September 2013, to determine BV incidence and factors associated with incident BV. Study methodology has been described in detail elsewhere [17, 21] .
Participants completed questionnaires and self-collected vaginal smears, and returned packs by post at 3-monthly intervals until the primary endpoint-incident BV, defined as a Nugent score (NS) of 7-10, or no BV (NS = 0-6) at 24 months. Research staff contacted participants to complete missing data for specific questions or if packs were not returned within 2 weeks. Packs not returned within 6 weeks were considered missing. Women were reminded by SMS (text message) to return additional questionnaires and a vaginal swab 1 and 2 weeks after first sexual contact with a new partner, or if they experienced interim BV symptoms.
Participants received results by post and AUD$20 for each returned pack and $40 at endpoint (incident BV or no BV at 24 months). Women diagnosed with BV received a letter to take to their physician for treatment. One of 3 experienced blinded microbiologists (G. F.) scored vaginal smears by the Nugent method. An independent microscopist rescored difficult to read and/or difficult to score slides, and consensus was reached. Scores were classified as follows: normal flora (NF), NS = 0-3; intermediate flora (IF), NS = 4-6; or BV, NS = 7-10. Women providing >1 set of microbiological and behavioral data were included in longitudinal analyses.
Statistical Methods
The primary aim was to measure BV incidence. A precisionbased sample size calculation was used. Assuming a 15% loss to follow-up over 24 months, a sample size of 300 women provided ±3% around an estimated incidence of 6% [18, 22] . Frequencies and 95% confidence intervals (CIs) of clinical and behavioral data were analyzed using Stata software, version 12.0. Logistic regression was used to examine differences in demographics, behaviors, and Nugent categories between noncoenrolled and coenrolled women, clustered for coenrolled partnerships. The BV incidence rate per 100 woman-years (WY) was calculated with Poisson 95% CIs, and rates were compared between non-coenrolled and coenrolled women. Multivariate Cox regression assessed whether baseline and longitudinal characteristics were predictors of BV as timedependent covariates and estimated hazard ratios (HRs). Data were censored when participants were diagnosed with BV, reached 24 months without BV, or were lost to follow-up/withdrew. Models were built sequentially starting with the characteristic most strongly associated with BV by univariate analysis and continued until no other variable reached significance.
Sexual partners (SPs) were classified into 3 groups: (i) coenrolled FSP: an FSP who was coenrolled, BV negative at baseline, and provided longitudinal behavioral and NS data; (ii) new SP within 90 days: a female or male partner with whom first sexual contact was within 90 days; and (iii) SP >90 days prior: a noncoenrolled female or male partner with whom first sexual contact commenced >90 days prior to sample collection, and may be an ongoing or short-term relationship. Analyses accounted for clustering at the coenrolled partnership level and were adjusted for age. Four sensitivity analyses were conducted, excluding (i) coenrolled couples; (ii) participants with prior BV; (iii) incident cases within 3 months; or (iv) sexual practices with men. An additional analysis examined factors associated with having stable NF to endpoint. P < .05 was considered statistically significant for analyses.
Ethical Approval
The Human Research and Ethics Committees of the Alfred Hospital (251/09) and University of Melbourne, Australia, approved this study. Written informed consent was obtained from all participants. 
RESULTS

Participation
The cohort population was derived from 458 women who participated in the cross-sectional study [17] . BV was detected in 124 (27% [95% CI, 23%-32%]) women at baseline. Three hundred thirty-four BV-negative women were invited to participate in the cohort; 298 (89%) enrolled, and 36 (11%) declined [21] . The majority of women were recruited at lesbian, gay, bisexual, transgender and intersex festivals (n = 149 [49%]), with the remainder enrolling through friends/partners (n = 65 [22%]), media/internet advertising (n = 48 [15%]), and health services Abbreviations: BV, bacterial vaginosis; FSP, female sexual partner; Hx, history; MSP, male sexual partner. a Logistic regression used to determine differences between non-coenrolled and coenrolled women and clustered for coenrolled partnerships.
b For sexual identity and smoking variables, "lesbian" or "nonsmoker" was used as the referent category, respectively.
c Less than 1% of participants have missing data for some variables; proportions are calculated using available data.
d Two women were not initially coenrolled but their partner enrolled within 4 months of them, and therefore they were coded as coenrolled for analyses.
e All continuous variables were dichotomized at median value.
f Calculated for women with a current female partner.
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(n = 36 [12%]). More-educated women and those with an FSP who coenrolled were more likely to participate, with smokers and women with prior BV or genital warts less likely to enroll, as described elsewhere [21] .
Demographic and Behavioral Characteristics of the Study Population
The study population comprised (i) 122 coenrolled women (61 couples) and (ii) 176 women not coenrolled with an FSP, although 117 (67%) reported a nonenrolled regular FSP (Table 1) . Median age was 30 years (interquartile range, 24-37 years); most participants were Australian born (83%) and had a tertiary (ie, postsecondary) education (86%). A history of BV was reported by 47 (16%) women, 20% were smokers, and 22% performed vaginal douching. In the year prior to enrollment, 39% of women reported a male sexual partner (MSP), and most reported engaging in oral sex, digital-vaginal sex, and toy use with an FSP. Coenrolled women differed from non-coenrolled women in that they were more likely to have a tertiary education and to report recent sex-toy use, but were less likely to smoke and had fewer lifetime and recent MSPs (Table 1) .
BV Incidence and Attrition
Of the 298 enrolled women, 248 were retained to study endpoint (retention rate, 83% [95% CI, 78%-87%]), 27 withdrew, and 23 were lost to follow-up [21] . Characteristics associated with attrition are described elsewhere [21] , but included having a current MSP and being <30 years of age. One hundred seventytwo (69%) participants returned every 3-month study pack until endpoint, and 76 (31%) participants skipped at least one 3-month interval of follow-up. There were 51 cases of incident BV and 523 WY of follow-up, yielding an incident rate of 9.75 per 100 WY (95% CI, 7.41-12.83; Table 2 ). Two-thirds of participants had stable NF throughout follow-up, and one-third transitioned between Nugent categories: 41 (14%) between NF and IF, 44 (15%) from NF to BV, and 7 (2%) from IF to BV. Coenrolled women were significantly less likely to have incident BV (P = .001) and more likely to have stable NF (odds ratio [OR], 2.57 [95% CI, 1.50-4.41]; Table 2 ).
Demographic and Behavioral Factors Associated With Incident BV and Stable NF
By univariate analysis, baseline characteristics associated with incident BV included no tertiary education, past BV, and >1 FSP in the year prior to enrollment ( A trend toward increased frequency of sexual contact and incident BV was observed in women reporting sex several times per week compared with women reporting sex once a month or less. We found no association between days since last menses, whether analyzed as a binary or continuous outcome. The variables significantly associated with incident BV were included in our multivariate model (Table 4 ). Many sexual practices were correlated with concurrent practices; for instance, receptive oral sex was reported in 72% of intervals in which digital-vaginal sex was reported. Receptive oral sex was included in our model as it was most strongly associated with incident BV (Table 4) Table 4 ). Receptive oral sex, having an FSP with BV symptoms, and onset of BV symptoms were also associated with 3-to 4-fold increased risk of incident BV. Coenrolled women had a significantly reduced BV risk (AHR, 0.26 [95% CI, .11-.61]). Age, past BV, and increased frequency of sex were not associated with incident BV.
As coenrolled partners had a reduced risk of incident BV, we undertook additional analyses and combined observation periods where women had sex with a monogamous coenrolled partner or had not engaged in any sexual practices with any sexual partners (no sex). This reference group was compared with observation periods where participants had sex with (i) an SP with whom first sexual contact was >90 days prior and (ii) a new SP with whom first sexual contact was <90 days prior. Compared with women who had no sex/exclusive coenrolled sex, women with a new SP within 90 days had an 8- 
Factors Associated With Concordance for Nugent Category and BV in Coenrolled Couples
The majority (74%) of coenrolled couples were concordant for Nugent category, two-thirds being concordant for NF (Table 6) . Sixteen couples had a discordant Nugent category, mainly representing NF/IF. When measured for concordance for BV (NS = 7-10) or no BV (NS = 0-6), 56 couples were concordant for BV/no BV (92%), and 5 were discordant (κ score = 0.24; P = .027; Table 6 ).
DISCUSSION
This community-based cohort study of women with FSPs yielded important findings that extend our understanding of the influence of sexual behaviors and relationships on the vaginal microbiota and risk of BV. Importantly, exposure to a new sexual partner and having a partner with BV symptoms were associated with an increased risk of acquiring BV. In contrast, coenrolled couples, who rarely had other partners, had a very low rate of BV, and their vaginal microbiota remained closely aligned and stable over prolonged periods. These data suggest that if a woman remains with a BV-negative partner, she has a very low risk of acquiring BV in the absence of new partnerships. This study provides epidemiological evidence to support transmission of vaginal bacterial species and BV between women.
Our observed BV incidence of 9.8 per 100 WY lies within previous incidence estimates, being similar to a community sample of Australian women who predominantly had sex with men (9.4/100 WY) [22] , but lower than a US cohort of WSW (23.2/100 WY) [18] and a US WSM population at risk of sexually transmitted infections (23.3/100 WY) [23] . Our findings that incident BV was associated with sex with a new partner, an FSP with BV symptoms, and receptive oral sex closely align with those of Marrazzo et al in the only other incidence study in WSW [18] . Importantly, both studies provide longitudinal data to support the concept that BV acquisition is strongly associated with exposure to a partner who is likely to have BV. BV incidence was greatest in participants who had a partner with noticeable BV symptoms, but with a background BV prevalence of 27% in Australian WSW [17] , one-quarter of women with a new FSP during the study were also likely to be exposed to BV. Recent sexual exposure, defined as having a new SP within 90 days, was associated with the greatest (8-fold) risk for incident BV, and exposure to a partner with whom first sexual contact had been >90 days prior was associated with a lesser, but still elevated (4-fold) risk compared with no sex or exclusive sex with a coenrolled partner. Importantly, our current data and previous recurrence data [24] indicate that frequency of sex is not contributing to BV risk. Although oral sex was associated with BV acquisition, it is unclear if this practice is important in the pathogenesis of BV, as this practice was common and highly concurrent with other practices such as digital-vaginal sex. Some lines of evidence suggest an association between b Refers to specific sexual relationships within each 3-month interval.
c Combination of women who reported interval(s) of no sex and women who reported exclusive monogamous sex with their coenrolled partner.
d Non-coenrolled partner(s) with whom first sexual contact commenced >90 days prior to sample collection.
e Sex with a new SP with whom first sexual contact was within 90 days, regardless of other partnerships. Missing data for variables included in this analysis occurred in <2% of intervals.
BV and oral sex. BV-associated bacteria such as Prevotella species, Fusobacterium species, and Gardnerella vaginalis have been detected in the oral cavity [25, 26] , there is evidence suggesting an association between BV and periodontal disease [27] [28] [29] , and BV and periodontal disease are both biofilm-associated conditions [12, 30] . Although oral sex is clearly not an essential act for acquisition of BV, this area requires further investigation. Traditional risk factors for BV, such as douching [31, 32] , smoking [15, 16, 33, 34] , prior BV [1] , lack of hormonal contraception [35] , and stage of menstrual cycle [18] , were not associated with incident BV in our cohort or that of Marrazzo et al [18, 20] , further supporting the dominance of sexual partnerships and sexual practices in acquisition of BV in WSW. Female same-sex relationships provide specific insight into the transmissibility of BV, as it can be diagnosed in both members of the partnership. Our long-term coenrolled couples yielded unique insights into BV pathogenesis and how partnerships influence the vaginal microbiota. At enrollment, coenrolled couples had longer-term relationships than women with a nonenrolled regular sexual partner, a lower BV prevalence, and high concordance of Nugent category [17] . These high rates of concordance were maintained throughout the 24 months of follow-up, and importantly these BV-negative partnerships conferred an extremely low risk of incident BV. High concordance for BV [13, 14, 16, 17] and sharing of Lactobacillus strains have been reported in cross-sectional studies of WSW couples by previous investigators [19] . Our data have shown for the first time that a female can exert a marked influence on her partner's vaginal microbiota that results in high levels of concordance over a sustained period.
Many studies utilizing rapid sampling have demonstrated frequent fluctuation in the vaginal microbiota [36] [37] [38] [39] , influenced by factors such as menstrual cycle and douching [36] [37] [38] . In contrast, our cohort of 298 women demonstrated that the vaginal microbiota was relatively stable over 2 years, with twothirds of women maintaining NF. Remarkable consistency was observed between our enrollment and longitudinal data, with two-thirds of the 458 women at enrollment also demonstrating stable NF over 14 days [17] . The most influential factor maintaining persistently stable NF was coenrollment with a regular BV-negative FSP. These data suggest that fluctuations in Nugent category are not necessarily a universal phenomenon across populations, with the vaginal microbiota remaining relatively stable long term in women at low sexual risk.
The WOW Health study was the largest cohort of communityrecruited WSW, with high retention rates over 2 years. We used screening methods to optimize the study of incident rather than recurrent BV, excluding women with BV using 3-weekly samples at enrollment, and conducting sensitivity analyses to exclude women with prior BV and incident BV within 3 months. Coenrollment of couples created a unique opportunity to assess the impact of behaviors and concordance of the vaginal microbiota over extended periods. Our study had a number of limitations. Our incidence estimates may have been lower than those in the general WSW community and US WSW cohort [18] , because our cohort contained women with lower traditional BV risk factors, including being highly educated and predominantly of white race. However, BV incidence was higher than a number of incidence studies in WSM [22, 40] . The 3-monthly follow-up may have resulted in delays in diagnosis of incident BV and recall bias; however, participants were encouraged to provide interim samples. The NS is a crude measure of the vaginal microbiota, but is the current gold standard in clinical trials, and renders findings generalizable to other published studies. Samples have been stored to further characterize the vaginal microbiota in this cohort.
This study provides evidence for dynamic exchange of vaginal bacterial species between FSPs and contributes to our understanding of how sexual behaviors and relationships influence the development of BV. Long-term coenrolled couples had a high level of concordance for a stable normal flora state and a very low risk of BV, providing evidence that a "healthy" stable vaginal microbiota confers benefit not just to the individual but to her FSP. Conversely, exposure to a new FSP from a population with a high background prevalence of BV, or a partner with BV symptoms, led to a high risk of BV acquisition. Data are presented as No. of couples (%). Normal flora defined as NS 0-3; IF, NS 4-6; BV, NS 7-10; no BV, NS 0-6. Discordance was defined using the highest Nugent category during follow-up. The majority of partners (67%) remained within NF at every interval during follow-up. However, if partner 1 developed IF or BV and partner 2 did not, they were coded as discordant.
These data have considerable clinical implications. They highlight the need in BV-positive WSW patients to consider partner screening and treatment, although partner screening and treatment have not been evaluated by randomized controlled trial. They are of relevance to WSM because if this evidence supports sexual transmission of vaginal species and BV between women, by extension it confirms and validates the need to revisit sufficiently powered male partner treatment trials. Collectively, published epidemiological data provide broad support for male and female partner treatment trials to determine if this strategy reduces BV recurrence and associated sequelae.
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